cyclosporine has been researched along with Corneal Angiogenesis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucak, YY; Çelebi, S; Erdurmus, M; Kükner, A; Terzi, EH | 1 |
| Bock, F; Böhringer, D; Christoph, J; Cursiefen, C; Ganslandt, T; Matthaei, M; Reinhard, T | 1 |
| Cejka, C; Cejkova, J; Holan, V; Sykova, E; Trosan, P; Zajicova, A | 2 |
| Behar-Cohen, F; Bourges, JL; Di Tommaso, C; Gurny, R; Jeanny, JC; Möller, M; Torriglia, A; Trubitsyn, G; Valamanesh, F | 1 |
| Al-Amri, A; Al-Torbak, A; Wagoner, MD | 1 |
| Shimazaki, J; Shimmura, S; Tomita, M; Tsubota, K | 1 |
| Beden, U; Erkan, D; Sonmez, B | 1 |
| Hill, JC; Horak, S; Maske, R | 1 |
| Rehany, U; Waisman, M | 1 |
| Benelli, U; Klintworth, GK; Nardi, M; Ross, JR | 1 |
| Epstein, RJ; Hendricks, RL; Lipman, RM | 2 |
| Derse, M; Payer, H; Rohrbach, JM; Wannke, E; Zierhut, M | 1 |
1 trial(s) available for cyclosporine and Corneal Angiogenesis
| Article | Year |
|---|---|
High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty.
Topics: Corneal Neovascularization; Cyclosporine; Drug Implants; Female; Germany; Humans; Immunosuppressive Agents; Incidence; India; Keratoplasty, Penetrating; Male; Middle Aged; Prospective Studies; United States | 2014 |
13 other study(ies) available for cyclosporine and Corneal Angiogenesis
| Article | Year |
|---|---|
Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Arthus Reaction; Bevacizumab; Biotin; Corneal Neovascularization; Cyclosporine; Deoxyuracil Nucleotides; Dexamethasone; Disease Models, Animal; Glucocorticoids; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Nick-End Labeling; Ophthalmic Solutions; Rabbits; Serum Albumin, Bovine | 2013 |
Transfer of mesenchymal stem cells and cyclosporine A on alkali-injured rabbit cornea using nanofiber scaffolds strongly reduces corneal neovascularization and scar formation.
Topics: Animals; Caustics; Cicatrix; Corneal Injuries; Corneal Neovascularization; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Immunosuppressive Agents; Mesenchymal Stem Cell Transplantation; Nanofibers; Rabbits; Sodium Hydroxide; Tissue Scaffolds; Wound Healing | 2016 |
Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.
Topics: Alkalies; Animals; Burns, Chemical; Caspase 3; Corneal Injuries; Corneal Neovascularization; Cyclosporine; Disease Models, Animal; Eye Burns; Female; Immunohistochemistry; Immunosuppressive Agents; Nanofibers; Rabbits; T-Lymphocytes; Vascular Endothelial Growth Factor A | 2016 |
Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Topics: Absorption; Administration, Ophthalmic; Administration, Topical; Animals; Chemistry, Pharmaceutical; Cornea; Corneal Neovascularization; Corneal Transplantation; Cyclosporine; Drug Carriers; Female; Graft Rejection; Graft Survival; Keratoplasty, Penetrating; Micelles; Ophthalmic Solutions; Rats; Rats, Inbred BN; Rats, Inbred Lew; Solubility; Surface-Active Agents | 2012 |
Deep corneal neovascularization after implantation with intrastromal corneal ring segments.
Topics: Adult; Combined Modality Therapy; Corneal Diseases; Corneal Neovascularization; Corneal Stroma; Cyclosporine; Device Removal; Dilatation, Pathologic; Drug Therapy, Combination; Humans; Male; Prednisolone; Prostheses and Implants; Prosthesis Implantation | 2005 |
Postkeratoplasty atopic sclerokeratitis in keratoconus patients.
Topics: Adult; Betamethasone; Blepharitis; Corneal Neovascularization; Cyclosporine; Dermatitis, Atopic; Female; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Incidence; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Scleritis; Time Factors; Visual Acuity | 2008 |
Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer.
Topics: Administration, Topical; Adolescent; Corneal Neovascularization; Corneal Stroma; Corneal Ulcer; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Male; Mycoses; Postoperative Care; Treatment Outcome | 2009 |
Mixed lymphocyte culture responses in rabbits undergoing corneal grafting and topical cyclosporine treatment.
Topics: Administration, Topical; Animals; Cornea; Corneal Neovascularization; Cyclosporine; Graft Rejection; Graft Survival; Histocompatibility Antigens; Keratoplasty, Penetrating; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Prospective Studies; Rabbits; Random Allocation; Transplantation, Homologous | 1994 |
Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
Topics: Animals; Burns, Chemical; Cornea; Corneal Injuries; Corneal Neovascularization; Cyclosporine; Eye Burns; Graft Rejection; Injections, Intramuscular; Keratoplasty, Penetrating; Rabbits; Sodium Hydroxide; Transplantation, Homologous | 1994 |
Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
Topics: Administration, Topical; Animals; Cautery; Cornea; Corneal Neovascularization; Corneal Transplantation; Cyclosporine; Drug Combinations; Guinea Pigs; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Subcutaneous; Male; Nitrates; Ophthalmic Solutions; Potassium Compounds; Rats; Rats, Inbred Lew; Silver Nitrate; Transplantation, Heterologous | 1997 |
Cyclosporine and neovascularization.
Topics: Animals; Corneal Neovascularization; Cyclosporine; Mice; T-Lymphocytes; Uveitis | 1999 |
[Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)].
Topics: Adult; Corneal Neovascularization; Corneal Ulcer; Cyclosporine; Deafness; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Ichthyosis; Immunosuppressive Agents; Male; Ophthalmic Solutions; Syndrome; Wound Healing | 2002 |
Suppression of corneal neovascularization with cyclosporine.
Topics: Animals; Corneal Neovascularization; Cyclosporine; Disease Models, Animal; Interleukin-2; Mice; Mice, Inbred A; Receptors, Interleukin-2; Recombinant Proteins | 1992 |